Grant Application for 2019-2021

Total Page:16

File Type:pdf, Size:1020Kb

Grant Application for 2019-2021 ISP Uppsala Universitet Deadline Box 549 IPPS 15 August 2018 SE-751 21 Uppsala, Sweden Fax +46184713495 IPICS 2 September2018 [email protected] I Grant application for 201I 9-2021 Research Groups and Scientific Networks Submit this application and enclosures by email attachment with a scanned/photographed copy of the first signed page. Read the separate document Guidelines for Enclosures and Budget for more information. Hover your pointer over theblueunderlinedwordsin this document for specific instructions.NOTE! ISP manages personal data (with care and only as long as necessary) provided on this form and in enclosures in order to honor the agreements with you and with Sida. Program Activity code(if settled) Chemistry X Other ☐ ANRAP Mathematics ☐ Physics ☐ Applicant(Research group leader/Network coordinator: title, given name, family name) EMERITUS PROFESSOR MOHAMMED MOSIHUZZAMAN Deputy: Address Department/unit: ANRAP Secretariat University/institute: Bangladesh University of Health Sciences(BUHS), Room No:C-14 Street (visiting address): Darussalam, Mirpur P.O Box number: Post/zip code: Dhaka-1216 City:Dhaka Country: Bangladesh E-mail address(es):[email protected];[email protected] Website: www.anrap.org Telephone and telefax Office Mobile Fax 88-02-8035501-06 8801755654160 (Ext 1312) Name of Research Group/NetworK ASIAN NETWORK OF RESEARCH ON ANTIDIABETIC PLANTS (ANRAP) City: Approved by the Department: ………………………………………………………/ Date: Signature by Head of Department/Name in printing: Summary of budget request (SEK) 2019 2020 2021 Total Equipment/spare parts/service 18,000 29,000 58,000 105,000 Consumables/literature/field work 68,000 76,000 76,000 220,000 Conferences/workshops 231,000 170,000 229,000 630,000 Exchange visits by cooperating scientists 10,000 10,000 8,000 28,000 Fellowships for training: 70,000 70,000 75,000 215,000 Support to students 10,000 20,000 10,000 40,000 Costs for audit and RG meeting 10,000 10,000 30,000 50,000 NetworK (only) administration costs 53,000 65,000 64,000 182,000 Total 470,000 450,000 550,000 1,470,000 The following enclosures are submitted Yes / No City: DhaKa 1) Research plan/network program Yes Date: 01 August 2018 2) Applicant’s/Deputy’s CV Yes 3) Publications/Theses/Abstracts Yes 4) Application for improving gender balance 5) Fellowship application(s) Applicant’s signature 6) Other (Specify:…………………………………………..........) Yes 1 (26) Deadline 2018 – see isp.uu.se/documents 1. Summary of proposed research/network activity (Research plan/Network program) (Full details should be given in Enclosure 1Please, carefully read and follow guidelines) Give a summary (half a page) of the research plan/networK program by briefly describing the planned activity and its justification, and for scientific research clarify the justification in relation to previous research/literature,postulate the hypotheses to be tested/research questions to be addressed, and indicate which methods will be used.Please note that this is a summary of Enclosure 1, Sections a – c. ANRAP was launched in Dhaka in 1994 as an outcome of collaborative research between BIRDEM and Dhaka University (DU) on antidiabetic plants. Since ANRAP was initiated in Dhaka, research activities on antidiabetic plants in the laboratories of BIRDEM and DU and now atBUHS became the focal point laboratory of the network. ANRAP acted as a planning coordinator and supervising organization to integrate the activities of various laboratories in the Asian Region.Through the course of time a number of important laboratories are now working synchronically under the umbrella of ANRAP. In the coming three years ANRAP will continue with its present activities of training Research Fellows from home and abroad, conduct National, Regional and International (every 3 years) Seminers and hold the hands-on-training workshop every year. Considering the practical use of herbal medicine specially in the poorer third world countries ANRAP has expanded its activityto scientifically evaluate antidiabetic herbal medicine (HM).HM, used for the treatment of other noncommunicable diseases will also be studied. In addition, in the next three years ANRAP will particularly give emphasis on the development of interlaboratory cooperation (NetHerb) for testing of herbal medicines. With this end in view ANRAP organized an International workshop on networking of ”Afro-Asian laboratories working on herbal medicine” in Dhaka, Bangladesh on 29-30 October, 2016 followed by a second meeting with representatives from laboratories in the Afro-Asian region in Kandy, Sri Lanka in January 2018.After detailed discussionsfour laboratories agreed to collaborate. An MOU will be signed among the collaborating laboratories in the upcoming 9th ANRAP International seminar that will be held in Karachi, Pakistan on 25-27 January, 2019. So the next target is to start in-depth research on herbal medicine incorporating Chemistry, Biochemistry, Pharmacology and ultimately preclinical toxicological studies and human trial. 2. Give an overview of objectives, planned outputs and expected outcomes Provide a summary of objectives, planned outputs and expected outcomes (and, if found convenient, formalized in the Logical Framework Matrix).Provide your answers under the below headings. This is a summary of Enclosure 1, Section d. 2 (26) Deadline 2018 – see isp.uu.se/documents Overall objective (impact) and relevance of the activity: ANRAP is a network of natural product scientists and participating laboratories working on or are planning to work on antidiabetic plant materials.During the last three years, research capabilities of Bangladesh University of Health Sciences (BUHS) has been strengthened. Chemistry and Pharmacology laboratories of BUHSare capable of conducting research on antidiabetic HM as well as on HM for other noncommunicable diseases. ANRAP has the following overall objectives: • Compilation of information on antidiabetic plants and herbal medicines reported in scientific literature and including those from producers,traditional healers, formal practitioners and users. • Conduct research on the chemical constituents and biological activities to assess the safety, efficacy and standardization of antidiabetic plants and herbal medicines used by millions of people across the world, and bring them within acceptable limits. • Isolation, characterization and testing of biological activity of pure compounds or fractions. • Optimize, coordinate and utilize the facilities existing in various laboratories for the purpose of fruitful research on antidiabetic plant materials and herbal medicine used for the management of diabetes and other non-communicable diseases prevalent in the region. Specific objectives for the granting period: • Training of young scientists and Fellowsincluding PhD studentsin the field of antidiabetic plant and HM research. • Holding of ANRAP Regional Workshop on Chemical Studies and Bioassay of antidiabetic plant materials (Participants will be from Bangladesh, Nepal, India, Pakistan, Sri Lanka, Malayasia and Mauritius) • Developing a network of herbal medicine(NetHerb) with representatives from different participating laboratories. • Evaluation of safety and efficacy of some antidiabetic HM and HM used for other diseases like hepatitis, hypertension and renal disorders. • Conducting preclinical and toxicological studies and clinical trial of some antidiabetic and other HM. 3 (26) Deadline 2018 – see isp.uu.se/documents • Arrange exchange of visits of scientists working in the field by arranging National, Regional and International (every 3 years) seminars on antidiabetic plants &herbal medicines and those used for other diseases. Expected outcomes of the activity: Scientific Results: • Masters and PhD thesis will be produced. Papers will bepublished in national and international journals. Patents on new scientifically evaluated herbal medicine can be produced. • More collaborative research linkage will be established. • Safety and efficacy of antidiabetic and other herbal medicine for other diseases will be evaluated. • Development of new drugs from plant and commercial herbal medicine through collaboration in national and international level. • An arrangement has been done between GK Pharma (Unani) Ltd to carry out chemical & biological studies on hepatotoxic model animals with hepatoprotective herbal drug (Holy Liv) produced in Bangladesh. Graduations: A number of post graduate students will be trained up. They will be working to produce their thesis and publish papers. Trained young scientists including post graduate students will be produced to work in the field of plant & herbal medicine research. Dissemination(publications/conference contributions,etc): • Training of young scientists and post graduate students. • National, Regional and International Workshops/Seminars on Chemistryand Biology of plant materials and herbal medicine for the management & treatment of diabetes and other diseases. • Publications of scientific articles in peer reviewed journals. • Conference reports/ Published Proceedings of Conferences. ScientificExchange A good number of exchange visits within the region and organizations of different national, regional and international Seminars & Conferences will enhance collaborative research and exchange of knowledge and skill of the researchers working in this field. 4 (26) Deadline 2018 – see isp.uu.se/documents Interactions with government and society (outreach): ANRAP has very good interaction with the Ministry of Science & Technology, Bangladesh Government
Recommended publications
  • Reports Based on the Work Performed by the Nordic Project Group on Inherent Natural Toxicants in Food Plants and Mushrooms Has Been Published
    Cucurbitacins in plant food Jørn Gry, Inge Søborg and Hans Christer Andersson TemaNord 2006:556 Cucurbitacins in plant food TemaNord 2006:556 © Nordic Council of Ministers, Copenhagen 2006 ISBN 92-893-1381-1 Print: Ekspressen Tryk & Kopicenter Copies: 200 Printed on environmentally friendly paper This publication can be ordered on www.norden.org/order. Other Nordic publications are available at www.norden.org/publications Printed in Denmark Nordic Council of Ministers Nordic Council Store Strandstræde 18 Store Strandstræde 18 DK-1255 Copenhagen K DK-1255 Copenhagen K Phone (+45) 3396 0200 Phone (+45) 3396 0400 Fax (+45) 3396 0202 Fax (+45) 3311 1870 www.norden.org The Nordic Food Policy Co-operation The Nordic Committee of Senior Officials for Food Issues is concerned with basic Food Policy issues relating to food and nutrition, food toxicology and food microbiology, risk evaluation, food control and food legislation. The co-operation aims at protection of the health of the consumer, common utilisation of professional and administrative resources and at Nordic and international developments in this field. Nordic co-operation Nordic co-operation, one of the oldest and most wide-ranging regional partnerships in the world, involves Denmark, Finland, Iceland, Norway, Sweden, the Faroe Islands, Greenland and Åland. Co- operation reinforces the sense of Nordic community while respecting national differences and simi- larities, makes it possible to uphold Nordic interests in the world at large and promotes positive relations between neighbouring peoples. Co-operation was formalised in 1952 when the Nordic Council was set up as a forum for parlia- mentarians and governments. The Helsinki Treaty of 1962 has formed the framework for Nordic partnership ever since.
    [Show full text]
  • Cucurbitacins – an Insight Into Medicinal Leads from Nature
    PHCOG REV. REVIEW ARTICLE Cucurbitacins – An insight into medicinal leads from nature Ujjwal Kaushik, Vidhu Aeri, Showkat R. Mir Department of Pharmacognosy and Phytochemistry, Phytochemistry Research Laboratory, Faculty of Pharmacy, New Delhi, India Submitted: 05‑03‑2014 Revised: 27‑03‑2014 Published: 05‑05‑2015 ABSTRACT Cucurbitacins which are structurally diverse triterpenes found in the members of Cucurbitaceae and several other plant families possess immense pharmacological potential. This diverse group of compounds may prove to be important lead molecules for future research. Research focused on these unattended medicinal leads from the nature can prove to be of immense significance in generating scientifically validated data with regard to their efficacy and possible role in various diseases. This review is aimed to provide an insight into the chemical nature and medicinal potential of these compounds exploring their proposed mode of action, probable molecular targets and to have an outlook on future directions of their use as medicinal agents. Key words: Cucurbitaceae, cucurbitacin, triterpenoids INTRODUCTION disease like diabetes. Plants from genus Trichosanthes have been used in China by herbal drug practitioners.[4] The purpose of this Plant secondary metabolites represent tremendous resources for review is to gather the information related to these highly diverse scientific and clinical research as well as for new drug development. group of compounds which may be useful in future research. Cucurbitacins are multiplex category of diverse compounds found in the plants of family Cucurbitaceae. Medicinal and toxic OCCURRENCE properties of these compounds have stimulated a continuing interest in them.[1] Many genus of Cucurbits viz. Trichosanthes, Cucurbitacins are found in many cucurbitaceous plants.
    [Show full text]
  • Ancient and Recent Medicinal Uses of Cucurbitaceae Family
    International Journal of Therapeutic Applications, Volume 9, 2013, 11-19 ANCIENT AND RECENT MEDICINAL USES OF CUCURBITACEAE FAMILY Shweta S. Saboo 1*, Priyanka K. Thorat 1, Ganesh G. Tapadiya 2, S S. Khadabadi 1 1 Department of Pharmacognosy, Govt. College of Pharmacy, Aurangabad, India 2 R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur, India known as 9β-methyl-19-nor lanosta-5-ene) (Fig. ABSTRACT 1) (Pryzek, 1979). The family Cucurbitaceae includes a The cucurbitacins are arbitrarily divided into large group of plants which are medicinally twelve categories, incorporating cucurbitacins A- valuable. It is a family of about 130 genera T. The various cucurbitacins differ with respect and about 800 species. Seeds or fruit parts to oxygen functionalities at various positions. of some cucurbits are reported to possess The structures of a few cucurbitacins (A, C, B purgatives, emetics and antihelmintics and D) are given in Fig. 2. These cucurbitacins properties due to the secondary metabolite are also present in their glycosidic forms such cucurbitacin content. A number of as cucurbitacin B glucoside containing glucose compounds of this group have been as the glycone moiety. 1 investigated for their cytotoxic, hepatoprotective, anti-inflammatory and cardiovascular effects. Cucurbitacins constitute a group of diverse triterpenoid substances which are well known for their bitterness and toxicity. They are highly oxygenated, tetracyclic triterpenes containing a cucurbitane skeleton characterized. The cucurbitacins are arbitrarily divided into twelve categories, incorporating cucurbitacins A-T. A lot of work has been done by the researchers throughout the world on various plants of Fig. 1 : Basic structure of cucurbitacins (19- the family Cucurbitaceae.
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]
  • Inhibitory Effects of Cucurbitane-Type Triterpenoids from Momordica
    molecules Article Inhibitory Effects of Cucurbitane-Type Triterpenoids from Momordica charantia Fruit on Lipopolysaccharide-Stimulated Pro-Inflammatory Cytokine Production in Bone Marrow-Derived Dendritic Cells Thao Quyen Cao 1,2,†, Nguyen Viet Phong 3,†, Jang Hoon Kim 4,† , Dan Gao 5, Hoang Le Tuan Anh 6, Viet-Duc Ngo 6, Le Ba Vinh 3,5, Young Sang Koh 7 and Seo Young Yang 8,* 1 Drug Research and Development Center, College of Pharmacy, Daegu Catholic University, Gyeongsan-si 38430, Korea; [email protected] 2 Institute of Pharmaceutical Research and Development, College of Pharmacy, Wonkwang University, Iksan 54538, Korea 3 Institute of Marine Biochemistry (IMBC), Vietnam Academy of Science and Technology (VAST), Hanoi 100000, Vietnam; [email protected] (N.V.P.); [email protected] (L.B.V.) 4 Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, RDA, Eumseon 27709, Korea; [email protected] 5 College of Pharmacy, Chungnam National University, Daejeon 34134, Korea; [email protected] 6 Center for Research and Technology Transfer, VAST, Hanoi 100000, Vietnam; [email protected] (H.L.T.A.); [email protected] (V.-D.N.) Citation: Cao, T.Q.; Phong, N.V.; 7 Department of Medicine, School of Medicine, Jeju National University, 102 Jejudaehakno, Jeju 63243, Korea; Kim, J.H.; Gao, D.; Anh, H.L.T.; Ngo, [email protected] 8 V.-D.; Vinh, L.B.; Koh, Y.S.; Yang, S.Y. Department of Pharmaceutical Engineering, Sangji University, Wonju 26339, Korea Inhibitory Effects of * Correspondence: [email protected]; Tel./Fax: +82-33-738-7652 Cucurbitane-Type Triterpenoids from † These authors contributed equally to this work.
    [Show full text]
  • Investigating the Chemical Space and Metabolic Bioactivation of Natural Products and Cross-Reactivity of Chemical Inhibitors in Cyp450 Phenotyping
    INVESTIGATING THE CHEMICAL SPACE AND METABOLIC BIOACTIVATION OF NATURAL PRODUCTS AND CROSS-REACTIVITY OF CHEMICAL INHIBITORS IN CYP450 PHENOTYPING Nicholas M. Njuguna Supervisor: Prof. Kelly Chibale Department of Chemistry, University of CapeTown Town Co-supervisor: Dr. Collen Masimirembwa African Institute of Biomedical Science andCape Technology, Harare, Zimbabwe of Thesis presented for the Degree of Doctor of Philosophy In the Department of Chemistry UniversityUNIVERSITY OF CAPE TOWN November 2014 The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is to be used for private study or non- commercial research purposes only. Published by the University of Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. Univeristy of Cape Town DECLARATION I, Nicholas Mwaura Njuguna, hereby declare that: (i) This thesis is my own unaided work, both in conception and execution, and that apart from the normal guidance of my supervisors; I have received no assistance apart from that acknowledged; (ii) Neither the substance nor any part of the thesis has been submitted in the past, or is to be submitted for a Degree in the University of Cape Town or any other University. Signed: Date: i DEDICATION To my family: Dad, Mum, Kim, Maureen, Joe and Shi For your enduring love, steadfast support and unshakeable belief that have made my journey into the unknown so much more bearable. ii ACKNOWLEDGEMENTS I wish to convey my heartfelt gratitude to all the people that contributed in every way, great or small, in the conceptualisation, execution and conclusion of this work.
    [Show full text]
  • Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites
    Review Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites Seong-Ah Shin 1,†, Sun Young Moon 1,†, Woe-Yeon Kim 2, Seung-Mann Paek 1, Hyun Ho Park 3,* and Chang Sup Lee 1,* 1 Collage of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Korea; [email protected] (S.-A.S.); [email protected] (S.Y.M.); [email protected] (S.- M.P.) 2 Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of Life Sciences (RILS), Gyeongsang National University, Jinju 52828, Korea; [email protected] (W. Y. K.) 3 College of Pharmacy, Chung-Ang University, Seoul 06974, Korea * Correspondence: [email protected] (H.H.P.); Tel.: +82-2-820-5930; [email protected] (C.S.L.); Tel.: +82- 55-772-2432 † These authors contributed equally to this work. Received: 24 July 2018; Accepted: 5 September 2018; Published: 6 September 2018 Abstract: A variety of malignant cancers affect the global human population. Although a wide variety of approaches to cancer treatment have been studied and used clinically (surgery, radiotherapy, chemotherapy, and immunotherapy), the toxic side effects of cancer therapies have a negative impact on patients and impede progress in conquering cancer. Plant metabolites are emerging as new leads for anti-cancer drug development. This review summarizes these plant metabolites with regard to their structures and the types of cancer against which they show activity, organized by the organ or tissues in which each cancer forms. This information will be helpful for understanding the current state of knowledge of the anti-cancer effects of various plant metabolites against major types of cancer for the further development of novel anti-cancer drugs.
    [Show full text]
  • Cucurbitane-Type Compounds from Momordica Charantia Isolation, In
    Bioorganic Chemistry 87 (2019) 31–42 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro T antidiabetic, anti-inflammatory activities and in silico modeling approaches Siddanagouda R. Shivanagoudraa, Wilmer H. Pereraa, Jose L. Pereza, Giridhar Athreyb, ⁎ ⁎ Yuxiang Sunc, G.K. Jayaprakashaa, , Bhimanagouda S. Patila, a Vegetable and Fruit Improvement Center, Department of Horticultural Sciences, Texas A&M University, 1500 Research Parkway, Suite A120, College Station, TX 77845, United States b Department of Poultry Science, Texas A&M University, College Station, TX 77845, United States c Department of Nutrition and Food Sciences, Texas A&M University, College Station, TX 77843, United States ARTICLE INFO ABSTRACT Keywords: Momordica charantia L., commonly known as bitter melon, belongs to the Cucurbitaceae family. Various in vitro Bitter melon and in vivo studies have indicated that extracts of bitter melons have anti-diabetic properties. However, very Cucurbitaceae little is known about the specific purified compounds responsible for these antidiabetic properties. In thepresent Triterpene aglycones study, 3β,7β,25-trihydroxycucurbita-5,23(E)-dien-19-al, charantal, charantoside XI, and 25ξ-isopropenylchole- Murine macrophages 5, 6-ene-3-O-D-glucopyranoside were isolated from bitter melon fruit. The structures of the purified compounds Molecular docking were elucidated by HR-ESIMS, 1D, and 2D NMR experiments. All compounds exhibited significant inhibition of α-amylase and α-glucosidase comparable to acarbose. Molecular docking studies demonstrated that purified compounds were able to bind to the active sites of proteins. Additionally, the purified compounds showed significant anti-inflammatory activity, downregulating the expression of NF-κB, iNOS, IL-6, IL-1β, TNF-α, and Cox-2 in lipopolysaccharide-activated macrophage RAW 264.7 cells.
    [Show full text]
  • The Studies on Momordica Charantia Fruits and the Synthesis of Pyrazolyl
    The studies on Momordica charantia fruits and the synthesis of pyrazolyl substituted benzylidene indanone derivatives as dengue virus type-2 NS2B/NS3 protease inhibitor Nadirah Zawani Mohd Nesfu To cite this version: Nadirah Zawani Mohd Nesfu. The studies on Momordica charantia fruits and the synthesis of pyrazolyl substituted benzylidene indanone derivatives as dengue virus type-2 NS2B/NS3 protease inhibitor. Organic chemistry. Université de Lorraine; Universiti Sains Malaysia (Malaisie), 2020. English. NNT : 2020LORR0092. tel-02969953 HAL Id: tel-02969953 https://hal.univ-lorraine.fr/tel-02969953 Submitted on 17 Oct 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. AVERTISSEMENT Ce document est le fruit d'un long travail approuvé par le jury de soutenance et mis à disposition de l'ensemble de la communauté universitaire élargie. Il est soumis à la propriété intellectuelle de l'auteur. Ceci implique une obligation de citation et de référencement lors de l’utilisation de ce document. D'autre part, toute contrefaçon, plagiat, reproduction illicite encourt une poursuite pénale. Contact : [email protected] LIENS Code de la Propriété Intellectuelle. articles L 122. 4 Code de la Propriété Intellectuelle.
    [Show full text]
  • Metabolite Profiling and Quantitation of Cucurbitacins in Cucurbitaceae
    www.nature.com/scientificreports OPEN Metabolite Profling and Quantitation of Cucurbitacins in Cucurbitaceae Plants by Liquid Chromatography coupled to Tandem Mass Spectrometry Faraz Ul Haq1, Arslan Ali2, Muhammad Noman Khan1, Syed Muhammad Zaki Shah1, Ram Chandra Kandel3, Nudrat Aziz1, Achyut Adhikari3, M. Iqbal Choudhary1,2,4, Atta-ur-Rahman1,2, Hesham R. El-Seedi5,6* & Syed Ghulam Musharraf 1,2* Cucurbitaceae is an important plant family because many of its species are consumed as food, and used in herbal medicines, cosmetics, etc. It comprises annual vines and is rich in various bioactive principles which include the cucurbitacins. These steroidal natural products, derived from the triterpene cucurbitane, are mainly the bitter principles of the family Cucurbitaceae. Their biological activities include anti-infammatory, hepatoprotective, and anti-cancer activities. A total of 10 species belonging to 6 genera of the Cucurbitaceae family along with Cissampelos pareira (Menispermaceae) were included in this study. A comprehensive profling of certain natural products was developed using HPLC- QTOF-MS/MS analysis and a distribution profle of several major natural products in this family was obtained. A total of 51 natural products were detected in both positive and negative ionization modes, based on accurate masses and fragmentation patterns. Along with this, quantitation of four bioactive cucurbitacins, found in various important plants of the Cucurbitaceae family, was carried out using multiple reaction monitoring (MRM) approach on an ion trap mass spectrometer. Cucurbitacin Q was found to be the most abundant in C. pareira, while Citrullus colocynthis contained all four cucurbitacins in abundant quantities. The developed quantitation method is simple, rapid, and reproducible.
    [Show full text]
  • European Journal of Chemistry 1 (4) (2010) 294‐296
    European Journal of Chemistry 1 (4) (2010) 294‐296 European Journal of Chemistry Journal homepage: www.eurjchem.com One new cucurbitane triterpenoid from the fruits of Momordica charantia Jie‐Qing Liu, Jian‐Chao Chen, Cui‐Fang Wang and Ming‐Hua Qiu* State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Science, Kunming, Yunnan, CN­650204, China *Corresponding author at: State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Science, Kunming, Yunnan, CN­650204, China. Tel.: +86.871.5223257; fax: +86.871.5223255. E­mail address: [email protected] (M.H. Qui). ARTICLE INFORMATION ABSTRACT Received: 29 May 2010 One new cucurbitane triterpenoid commonly named neokuguaglucoside, together with three Received in revised form: 24 September 2010 known compounds momordicoside M, momordicoside N, and momordicoside A were Accepted: 18 October 2010 isolated from the fresh fruits of Momordica charantia. The new one’s structure with an Online: 31 December 2010 interesting sugar‐like groups attached to the side chain was elucidated by spectroscopic analysis and semiepirical (AM1) quantum chemical method. KEYWORDS Momordica charantia Cucurbitane triterpenoids Neokuguaglucoside Semi‐empirical quantum chemistry methods AM1 1. Introduction 2. Experimental The plant Momordica charantia L. is cultivated in Asian 2.1. General experimental procedures countries. Its fruit was called “kugua” in China and bitter melon in western country. It is a favorable vegetable in China and Optical rotations were recorded on a HORIBA SEPA‐300 becoming increasingly popular as a food supplement to lower digital polarimeter using a sodium lamp.
    [Show full text]
  • An RP-LC-UV-TWIMS-HRMS and Chemometric Approach To
    molecules Article An RP-LC-UV-TWIMS-HRMS and Chemometric Approach to Differentiate between Momordica balsamina Chemotypes from Three Different Geographical Locations in Limpopo Province of South Africa Pieter Venter 1,*, Kholofelo Malemela 1,2, Vusi Mbazima 2 , Leseilane J. Mampuru 2 , Christo J. F. Muller 1,3 and Sylvia Riedel 1,3,* 1 Biomedical Research and Innovation Platform, South African Medical Research Council, P.O. Box 19070, Tygerberg 7505, South Africa; [email protected] (K.M.); [email protected] (C.J.F.M.) 2 Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo, Private Bag x1106, Sovenga 0727, South Africa; [email protected] (V.M.); [email protected] (L.J.M.) 3 Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 241, Cape Town 8000, South Africa * Correspondence: [email protected] (P.V.); [email protected] (S.R.); Tel.: +27-21-938-0421 (P.V.); +27-21-938-0844 (S.R.) Abstract: Momordica balsamina leaf extracts originating from three different geographical locations Citation: Venter, P.; Malemela, K.; were analyzed using reversed-phase liquid chromatography (RP-LC) coupled to travelling wave ion Mbazima, V.; Mampuru, L.J.; Muller, mobility (TWIMS) and high-resolution mass spectrometry (HRMS) in conjunction with chemometric C.J.F.; Riedel, S. An analysis to differentiate between potential chemotypes. Furthermore, the cytotoxicity of the three RP-LC-UV-TWIMS-HRMS and individual chemotypes was evaluated using HT-29 colon cancer cells. A total of 11 molecular species Chemometric Approach to including three flavonol glycosides, five cucurbitane-type triterpenoid aglycones and three glycosidic Differentiate between Momordica cucurbitane-type triterpenoids were identified.
    [Show full text]